Literature DB >> 32050285

[Diffuse malignant peritoneal mesothelioma (DMPM) - a rare diagnosis].

Victoria Susanne Antonia Habbel1, Elisa Annabelle Mahler2, Bernd Feyerabend3, Karl-Jürgen Oldhafer1, Michael Josef Lipp1.   

Abstract

Diffuse malignant peritoneal mesothelioma (DMPM) is a rare diagnosis, found more frequently in men than in women. Symptoms are unspecific abdominal disorders making that diagnosis difficult to set. Causes of DMPM are yet to be discovered in entirety. Asbestos exposure is the reason for approximately 7 % of all peritoneal mesotheliomas. Until the evaluation of systematic cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) DMPM was a fatal diagnosis with a median overall survival (OS) of 4-13 months. The prognosis of DMPM dramatically improved with implementation of CRS and HIPEC to an OS of 30-92 month nowadys. CRS and HIPEC were performed in this case. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Year:  2020        PMID: 32050285     DOI: 10.1055/a-1083-6962

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  1 in total

1.  Efficacy and Adverse Events of Apatinib Salvage Treatment for Refractory Diffuse Malignant Peritoneal Mesothelioma: A Pilot Study.

Authors:  Zhi-Ran Yang; Yan-Dong Su; Ru Ma; He-Liang Wu; Yan Li
Journal:  Front Oncol       Date:  2022-07-01       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.